Federated Hermes, Inc. Zentalis Pharmaceuticals, Inc. Transaction History

Federated Hermes, Inc.

$43.9 Billion
Q1 2025

A detailed history of Federated Hermes, Inc. transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 752,517 shares of ZNTL stock, worth $1.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

752,517

Previous 493,982 52.34%

Holding current value

$1.11 Million

Previous $1.5 Million 20.05%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	BUY	$1.59 - $3.24 $411,070 - $837,653	258,535 Added 52.34%	752,517 $1.2 Million
Q4 2024 Feb 13, 2025	BUY	$2.7 - $4.03 $28,738 - $42,895	10,644 Added 2.2%	493,982 $1.5 Million
Q3 2024 Nov 13, 2024	BUY	$2.9 - $4.57 $2,485 - $3,916	857 Added 0.18%	483,338 $1.77 Million
Q2 2024 Aug 08, 2024	SELL	$4.09 - $16.13 $6.2 Million - $24.5 Million	-1,516,219 Reduced 75.86%	482,481 $1.97 Million
Q1 2024 May 14, 2024	SELL	$10.83 - $16.49 $1.75 Million - $2.67 Million	-161,865 Reduced 7.49%	1,998,700 $31.5 Million
Q4 2023 Jan 31, 2024	BUY	$9.84 - $20.13 $2.09 Million - $4.29 Million	212,872 Added 10.93%	2,160,565 $32.7 Million
Q3 2023 Nov 13, 2023	SELL	$19.63 - $28.29 $1.38 Million - $2 Million	-70,541 Reduced 3.5%	1,947,693 $39.1 Million
Q2 2023 Aug 14, 2023	BUY	$17.41 - $30.05 $9.25 Million - $16 Million	531,236 Added 35.73%	2,018,234 $56.9 Million
Q1 2023 May 08, 2023	BUY	$16.14 - $24.94 $4.44 Million - $6.87 Million	275,398 Added 22.73%	1,486,998 $25.6 Million
Q4 2022 Feb 13, 2023	BUY	$18.07 - $25.6 $2.26 Million - $3.2 Million	125,000 Added 11.5%	1,211,600 $24.4 Million
Q3 2022 Nov 14, 2022	BUY	$20.23 - $31.73 $29,556 - $46,357	1,461 Added 0.13%	1,086,600 $23.5 Million
Q2 2022 Aug 15, 2022	BUY	$17.91 - $52.25 $2.4 Million - $7.01 Million	134,206 Added 14.11%	1,085,139 $30.5 Million
Q1 2022 May 13, 2022	SELL	$41.58 - $80.89 $986,568 - $1.92 Million	-23,727 Reduced 2.43%	950,933 $43.9 Million
Q4 2021 Feb 14, 2022	SELL	$66.92 - $84.79 $20.6 Million - $26.1 Million	-307,723 Reduced 24.0%	974,660 $81.9 Million
Q3 2021 Nov 15, 2021	BUY	$46.83 - $73.5 $361,387 - $567,199	7,717 Added 0.61%	1,282,383 $85.5 Million
Q2 2021 Aug 16, 2021	SELL	$37.41 - $62.25 $4.85 Million - $8.07 Million	-129,673 Reduced 9.23%	1,274,666 $67.8 Million
Q1 2021 May 13, 2021	BUY	$35.69 - $52.72 $22.3 Million - $33 Million	625,264 Added 80.26%	1,404,339 $60.9 Million
Q3 2020 Nov 12, 2020	BUY	$27.03 - $47.97 $21.1 Million - $37.4 Million	779,075 New	779,075 $25.5 Million

Others Institutions Holding ZNTL

# of Institutions

140

Shares Held

60.7M

Call Options Held

7.9K

Put Options Held

42.5K

View Full List

About Zentalis Pharmaceuticals, Inc.

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $83.8M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

More about ZNTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Zentalis Pharmaceuticals, Inc. Transaction History